Bacterium-like particles supplemented with inactivated influenza antigen induce cross-protective influenza-specific antibody responses through intranasal administration.

Related Articles

Bacterium-like particles supplemented with inactivated influenza antigen induce cross-protective influenza-specific antibody responses through intranasal administration.

This entry was posted in Vaccine and tagged . Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *